News Cronos continues cash burn with US$161M loss in Q1 With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture Jared GnamMay 7, 2021
Industry update Cronos stock drops on US$111.7M Q4 loss Despite continued cash burn, the Canadian pot firm remains bullish on its Kristen Bell-partnered US CBD brand Happy Dance Jared GnamFebruary 26, 2021